Definium Therapeutics, Inc. · NASDAQ:DFTX

Barrow Robert received 375,000 Definium Therapeutics, Inc. shares as an award (Form 4)

Traded Jun 22, 2026 · Filed Jun 22, 2026

On Jun 22, 2026, Barrow Robert (Director, Chief Executive Officer) received 375,000 Definium Therapeutics, Inc. shares as an award, leaving 1,127,454 shares. Filed Jun 22, 2026 (Form 4).

Awarded
375,000 shares
Holding after
1,127,454 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 22, 2026Common SharesAward375,0001,127,454Direct

Source

View original at SEC

Related